HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevention of recurrent urinary tract infections in premenopausal women by post-coital administration of cinoxacin.

Abstract
A total of 21 sexually active premenopausal women, prone to recurrent urinary tract infections but who otherwise were healthy, underwent post-coital prophylaxis consisting of bladder voiding and a single 250 mg. tablet of cinoxacin. While 94 urinary tract infections occurred during a mean of 7.5 months before treatment, only 8 occurred during a mean of 12.5 months after prophylaxis. This difference was statistically highly significant. A mean of 106 cinoxacin tablets per patient were administered during post-coital prophylaxis. Cinoxacin represents an additional valuable and effective antibacterial in post-coital prophylaxis of recurrent urinary tract infection in otherwise healthy premenopausal women, although it is slightly less effective than cotrimoxazole or nitrofurantoin. Effective post-coital prophylaxis requires the use of much smaller quantities of antibacterial agents than the daily use of a single tablet and in women with a high incidence of recurrent urinary tract infections it is superior to intermittent self-administered antibacterial therapy.
AuthorsA Pfau, T G Sacks, M Shapiro
JournalThe Journal of urology (J Urol) Vol. 139 Issue 6 Pg. 1250-2 (Jun 1988) ISSN: 0022-5347 [Print] United States
PMID3286892 (Publication Type: Journal Article)
Chemical References
  • Pyridazines
  • Cinoxacin
Topics
  • Adult
  • Cinoxacin (administration & dosage, therapeutic use)
  • Coitus
  • Drug Administration Schedule
  • Escherichia coli Infections (prevention & control)
  • Female
  • Humans
  • Pyridazines (therapeutic use)
  • Recurrence
  • Urinary Tract Infections (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: